| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.59▲ | 8.58▲ | 8.65▼ | 8.87▼ | 8.33▲ |
| MA10 | 8.56▲ | 8.70▼ | 8.78▼ | 8.89▼ | 8.17▲ |
| MA20 | 8.55▲ | 8.82▼ | 8.91▼ | 8.43▲ | 8.55▲ |
| MA50 | 8.68▼ | 8.95▼ | 8.91▼ | 8.07▲ | 12.65▼ |
| MA100 | 8.81▼ | 8.95▼ | 8.69▼ | 8.62▼ | 13.40▼ |
| MA200 | 8.93▼ | 8.62▼ | 8.19▲ | 11.71▼ | 13.72▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.018▲ | -0.029▼ | -0.049▼ | 0.027▲ | 0.353▲ |
| RSI | 52.013▲ | 35.743▼ | 36.920▼ | 52.918▲ | 42.160▼ |
| STOCH | 73.382 | 14.328▼ | 12.441▼ | 60.244 | 57.368 |
| WILL %R | -13.043▲ | -74.510 | -77.586▼ | -46.154 | -30.435 |
| CCI | 138.462▲ | -95.966 | -130.525▼ | -3.355 | 93.270 |
|
Wednesday, June 04, 2025 01:39 PM
Cullinan Therapeutics (NASDAQ:CGEM) signed a deal with Genrix Bio for an exclusive license for velinotamig, a bispecific T cell engager. As per the deal, Cullinan will pay Genrix Bio a $20M upfront ...
|
|
Thursday, May 29, 2025 04:00 AM
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing ...
|
|
Saturday, May 24, 2025 09:14 PM
Short interest in Cullinan Therapeutics Inc (NASDAQ:CGEM) decreased during the last reporting period, falling from 7.99M to 7.48M. This put 14.66% of the company's publicly available shares short.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 8.80 | 8.96 | 8.47 | 8.61 | 264,276 |
| 12/06/25 | 8.92 | 9.06 | 8.76 | 8.95 | 183,913 |
| 11/06/25 | 9.15 | 9.25 | 8.94 | 8.98 | 346,983 |
| 10/06/25 | 8.90 | 9.15 | 8.80 | 9.04 | 193,282 |
| 09/06/25 | 9.25 | 9.28 | 8.64 | 8.76 | 355,917 |
| 06/06/25 | 8.86 | 9.10 | 8.57 | 9.08 | 370,550 |
| 05/06/25 | 8.97 | 9.00 | 8.4801 | 8.74 | 327,829 |
| 04/06/25 | 8.96 | 9.36 | 8.95 | 9.07 | 307,735 |
| 03/06/25 | 8.81 | 9.13 | 8.76 | 8.96 | 338,659 |
| 02/06/25 | 8.76 | 9.12 | 8.46 | 8.75 | 436,478 |
|
|
||||
|
|
||||
|
|